Skip to content

Intangibles (Net) at other companies

Zoetis logo
ZoetisZTS
$745M-14.9%
Idexx Laboratories logo
Idexx LaboratoriesIDXX
$104.75M-2.5%
Kenvue logo
KenvueKVUE
$3.67B-3.4%
General Mills logo
General MillsGIS
$7.03B+2,534%
Archer Daniels Midland logo
Archer Daniels MidlandADM

Other financials

Income statement

See full
Revenue$1.4B+14.9%
Gross profit$785.0M+14.8%
Net income$57.0M-14.9%
EPS (diluted)$0.11-15.4%

Balance sheet

See full
Cash & equivalents$428.0M-12.1%
Total debt$4.3B-1.7%
Total equity$6.5B+2.3%
Total assets$13.2B+2.2%

Cash flow

See full
Operating cash flow$13.0M+425%
CapEx$51.0M-21.5%
Free cash flow-$38.0M+44.9%

Valuation

See full
Market cap$12.1B+128%
Enterprise value$15.99B+73.1%
P/S2.5×+1.3×

Profitability

See full
Gross margin55.1%+0.2pp
Net margin-4.9%-13.6pp
FCF margin6.4%-1.4pp

Returns & leverage

See full
Return on equity-3.8%-9.9pp
Debt / equity0.7×0.0×
Current ratio2.2×-0.6×

Where this comes from

Reported directly by Elanco Animal Health Inc. in its filing.

Tagged under the XBRL concept us-gaap:IntangibleAssetsNetExcludingGoodwill.

The official record: Elanco Animal Health Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Elanco Animal Health Inc.'s intangibles (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Elanco Animal Health Inc.'s intangibles (net)?
Elanco Animal Health Inc. (ELAN) reported intangibles (net) of $3.23B in Q1 2026.
How has Elanco Animal Health Inc.'s intangibles (net) changed year-over-year?
Elanco Animal Health Inc.'s intangibles (net) decreased by 11.3% year-over-year, from $3.63B to $3.23B.
What is the long-term trend for Elanco Animal Health Inc.'s intangibles (net)?
Over 5 years (2020 to 2025), Elanco Animal Health Inc.'s intangibles (net) has grown at a -11.8% compound annual growth rate (CAGR), from $6.39B to $3.41B.
What does intangibles (net) mean?
The value of non-physical assets like patents and trademarks, minus accumulated amortization.
How do you interpret intangibles (net)?
A high value suggests a strong portfolio of intellectual property, while a declining value may indicate the approaching expiration of key patents.
How does intangibles (net) compare across companies?
Highly relevant for life sciences and pharma; benchmarked against R&D investment and patent life cycles.